Vaxcyte Inc (PCVX)
Healthcare
Biotechnology
53.50 $
-1.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Vaxcyte Inc (PCVX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -281 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -63 | -58 | -129 | -159 | -121 | -61 | -111 | -166 | -121 | -143 | -225 | -281 | -770 | |
| 2.4 | 2.5 | 2.9 | 3.1 | 3.5 | 4.5 | 4.8 | 4.9 | 5.0 | 5.2 | 9.8 | 5.9 | 26 | |
| 13 | 13 | 13 | 18 | 22 | 21 | 24 | 31 | 37 | 35 | 36 | 38 | 146 | |
| 0.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.5 | 34 | 38 | -74 | -7.8 | 29 | -2.5 | -50 | 34 | 32 | 3.7 | -2.9 | 67 | |
| 2.1 | 7.3 | 57 | 12 | 45 | 38 | 30 | 27 | 20 | 12 | 5.6 | 15 | 52 | |
| -334 | 22 | -14 | -451 | -80 | -917 | -557 | 123 | 78 | 121 | 115 | -233 | 81 | |
| -0.2 | -2.6 | 5.6 | -3.3 | -0.6 | 5.5 | – | – | – | – | – | – | – | |
| 547 | 49 | 2.7 | 818 | 110 | 1,515 | 4.9 | 0.8 | 2.5 | -3.7 | 2.4 | 602 | 603 | |
| 151 | 14 | -148 | 214 | -93 | 532 | -662 | -41 | -40 | -26 | -107 | 87 | -86 | |
| -61 | -65 | -186 | -171 | -167 | -99 | -141 | -193 | -102 | -155 | -219 | -295 | -772 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.